In Acute Myeloid Leukemias (AML), FLT3 inhibitors enhance the sensitivity of FLT3-mutant AML cells to lipid oxidative stress by inhibiting the C/EBPα/SCD axis, thereby inducing ferroptosis (Sabatier et al., 2023). The gene discussed is SCD; the disease is acute myeloid leukemia.